StonePrime
StonePrime provides objective analysis of scientific research to guide biotech investments for institutional portfolios. It uses quantitative and qualitative AI to score and prioritize targets, translating complex data into actionable insights for decision-makers. The system aggregates research outputs and market signals to benchmark opportunities, applying AI-powered analytics and sentiment assessment. It functions as a B2B investment analytics platform, enabling integration with existing data feeds and portfolio workflows. The goal is to scale thematic biotech investments with rigor and transparency across markets.
StonePrime
StonePrime provides objective analysis of scientific research to guide biotech investments for institutional portfolios. It uses quantitative and qualitative AI to score and prioritize targets, translating complex data into actionable insights for decision-makers. The system aggregates research outputs and market signals to benchmark opportunities, applying AI-powered analytics and sentiment assessment. It functions as a B2B investment analytics platform, enabling integration with existing data feeds and portfolio workflows. The goal is to scale thematic biotech investments with rigor and transparency across markets.